News

2026.08.27 / COMPANYxFOREST Therapeutics Establishes a Drug Discovery Strategy Division and New Management Structure to Accelerate Its PipelineSEE DETAILS → 2026.04.10 / PARTNERSHIPxFOREST Therapeutics Announces Drug Discovery Collaboration with Nippon Shinyaku to Target RNA Structures in Several DiseasesSEE DETAILS → 2026.04.09 / PUBLICATIONPublication of a Paper on Compound Design for RNA-Targeted Drug DiscoverySEE DETAILS → 2026.03.24 / PUBLICATIONOur Intern Emi Miyashita and CTO Kaoru Komatsu Report Variant-Specific RNA Interaction Mechanisms in Nature CommunicationsSEE DETAILS → 2025.11.06 / MILESTONExFOREST Therapeutics Announces Progress in Research Collaboration with Astellas PharmaSEE DETAILS → 2025.09.18 / PARTNERSHIPxFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug DiscoverySEE DETAILS → 2025.07.23 / MILESTONExFOREST Therapeutics Achieves a Milestone in Drug Discovery Collaboration with OtsukaSEE DETAILS → 2025.06.10 / MILESTONExFOREST Therapeutics Achieves a Third Milestone in Drug Discovery Collaboration with TakedaSEE DETAILS → 2025.05.01 / COMPANYxFOREST Therapeutics has Reached its 5th Anniversary (CEO Message)SEE DETAILS → 2025.04.25 / PARTNERSHIPxFOREST Therapeutics Announces Drug Discovery Collaboration with Astellas for Targeting RNA Splicing in Multiple DiseasesSEE DETAILS → 2025.03.13 / RECOGNITIONxFOREST Therapeutics to be Certified as a “J-Startup” by the Ministry of Economy, Trade and IndustrySEE DETAILS → 2025.01.24 / MILESTONExFOREST Announces Receipt of Milestone Payment from Kyowa KirinSEE DETAILS → 2025.01.24 / FUNDINGxFOREST Announces Closing of Series A Funding RoundSEE DETAILS → 2024.12.13 / FUNDINGAwarded a Grant from NEDO's Deep Tech Startup Support Program (NEDO PCA)SEE DETAILS → 2024.08.26 / EVENTPresenting at the 28th EFMC International Symposium on Medicinal ChemistrySEE DETAILS → 2024.03.01 / MILESTONExFOREST Therapeutics Achieves a 2024 Milestone in Drug Discovery Collaboration with TakedaSEE DETAILS → 2024.02.09 / RECOGNITIONxFOREST Therapeutics to be Certified as a “J-Startup KANSAI”SEE DETAILS → 2023.12.14 / EVENTCEO Shunichi Kashida Delivered a Keynote Speech at the 6th RNA-Targeted Drug Discovery & Development Summit in BostonSEE DETAILS → 2023.11.15 / EVENTOral and Poster Presentations at the 40th Medicinal Chemistry Symposium (MCS2023)SEE DETAILS → 2023.11.03 / RECOGNITIONEmi Miyashita Received the Outstanding Poster Award at the 50th International Symposium on Nucleic Acids ChemistrySEE DETAILS → 2023.10.07 / EVENTParticipation in the EU-Japan Biotech & Pharma Partnering Conference 2023SEE DETAILS → 2023.08.31 / RECOGNITIONYasutoshi Nishimura, Minister of Economy, Trade and Industry, Visited Our LaboratorySEE DETAILS → 2023.05.26 / EVENTCEO Shunichi Kashida Delivered a Lecture at the 445th Meeting of the Chem-Bio Informatics SocietySEE DETAILS → 2022.10.24 / COMPANYCEO Shunichi Kashida Featured in the CiRA NewsletterSEE DETAILS → 2022.06.13 / PARTNERSHIPOtsuka Enters Collaboration with xFOREST Therapeutics on RNA Structure-Targeted Drug DiscoverySEE DETAILS → 2022.04.01 / FUNDINGAwarded the Innovative Technology Grant Program (Monozukuri Hojokin)SEE DETAILS → 2021.11.01 / PARTNERSHIPxFOREST Therapeutics, Axcelead DDP and Kyowa Kirin Initiated Collaboration in RNA Structure-Targeted Drug DiscoverySEE DETAILS → 2021.07.27 / RECOGNITIONReceived the EMBO Reports Award at the 22nd Annual Meeting of the RNA Society of JapanSEE DETAILS → 2021.07.01 / PUBLICATIONOur CTO Published a Paper on a Fluid Flow-Dependent mRNA Degradation Mechanism in Nature CommunicationsSEE DETAILS → 2021.03.23 / PARTNERSHIPxFOREST Therapeutics Announces Drug Discovery Collaboration with Daiichi SankyoSEE DETAILS → 2021.03.17 / RECOGNITIONCertified as an “A Rank Company” by the Kyoto City Venture Companies Evaluation CommitteeSEE DETAILS → 2020.12.08 / PUBLICATIONOur CTO and CEO Published a Paper on the Basics of FOREST TechnologySEE DETAILS → 2020.10.23 / FUNDINGAwarded a Grant from NEDO's Seed-stage Startup Support Program (NEDO STS)SEE DETAILS → 2020.10.06 / PARTNERSHIPxFOREST Therapeutics Announces Drug Discovery Collaboration with TakedaSEE DETAILS → 2020.10.06 / FUNDINGxFOREST Announces Closing of Seed Funding RoundSEE DETAILS → 2020.08.19 / FUNDINGAwarded a Grant from Kyoto CitySEE DETAILS → 2020.07.01 / PARTNERSHIPxFOREST Therapeutics Announces Research Collaboration with Tohoku UniversitySEE DETAILS → 2020.05.01 / PARTNERSHIPxFOREST Therapeutics Announces Research Collaboration with the Center for iPS Cell Research and Application, Kyoto UniversitySEE DETAILS → 2020.05.01 / COMPANYWe Started Our Company, “xFOREST Therapeutics Co., Ltd.”SEE DETAILS → 2020.01.08 / RECOGNITIONJoined the Start-up Accelerator Program “Open Network Lab BioHealth 2nd Batch”SEE DETAILS → 2019.07.19 / RECOGNITIONAwarded the “KYOTO Entrepreneurship Development Program 2019”SEE DETAILS → 2019.07.08 / RECOGNITIONKaoru Richard Komatsu Received the Best Award at Bayer × Sysmex “Pitch Your Dreams in KOBE 2019”SEE DETAILS → 2019.03.01 / FUNDINGAwarded Incubation Funding by Kyoto UniversitySEE DETAILS →